OSXOSTEOPORE LIMITED

Announcement history available from 1 August 2025

Fromto
Date / TimeTitleTypeMSReport Codes
6 Aug 2026, 18:45OSX strikes orthopaedic deal for 5 Middle East countriesCompany UpdateMS11001
4 Aug 2026, 04:25Details of Auditor Appointment/ResignationOther12018
3 Aug 2026, 18:35OSX completes first Hainan custom orthopaedic implantCompany Update11001
31 July 2026, 19:01Activities Report June 2026 and Appendix 4CQuarterly ReportsMS03026, 19002, 19007
24 July 2026, 04:52Application for quotation of securities - OSXOther06020
14 July 2026, 18:43First OSX custom orthopaedic implant delivered to HainanCompany Update11001
7 July 2026, 18:34OSX & Zimmer gain craniofacial market access to Saudi ArabiaCompany Update11001
2 July 2026, 18:24OSX completes co-development project for neurosurgical guideCompany Update11001
30 June 2026, 18:52First patient treated in OSX-PAH jaw reconstruction trialCompany Update11001
29 June 2026, 18:26First 2 patients treated in QCH cleft lip clinical trialCompany Update11001
26 June 2026, 18:17QCH cleft lip clinical study patient recruitment completedCompany Update11001
24 June 2026, 18:52OSX neuro products approved in a major centre in ThailandCompany Update11001
23 June 2026, 19:02Cleansing NoticeSecurities Administration06009, 06018
23 June 2026, 18:57Notification regarding unquoted securities - OSXOther06021
23 June 2026, 18:51Further Drawdown of T2 of the Redeemable Convertible NotesSecurities AdministrationMS06009
22 June 2026, 18:41First OSX custom orthopaedic implant completed in Hong KongCompany Update11001
17 June 2026, 18:51OSX & DKSH Malaysia dental launch First products deliveredCompany Update11001
16 June 2026, 04:41Notification of cessation of securities - OSXOther06027
11 June 2026, 04:12Becoming a substantial holderSubstantial Holders02001
10 June 2026, 05:02Ceasing to be a substantial holderSubstantial Holders02003
9 June 2026, 19:03Application for quotation of securities - OSXOther06020
2 June 2026, 19:08OSX & QCH launch trial for nasoalveolar augment in childrenCompany Update11001
29 May 2026, 04:45Change in substantial holdingSubstantial Holders02002
26 May 2026, 18:59OSX secures Hainan FDA approval for orthopaedic devicesCompany UpdateMS11001
22 May 2026, 00:10Results of Annual General MeetingMeetings & Governance08003
15 May 2026, 18:46OSX orthopaedic products gain Malaysian market access rightsCompany Update11001
12 May 2026, 23:09Cleansing NoticeSecurities Administration06018
12 May 2026, 23:05Application for quotation of securities - OSXOther06020
4 May 2026, 23:08Becoming a substantial holderSubstantial Holders02001
2 May 2026, 03:22Application for quotation of securities - OSXOther06020
30 Apr 2026, 18:32Activities Report March 2026 and Appendix 4CQuarterly ReportsMS03026, 19001, 19006
23 Apr 2026, 18:53Ceasing to be a substantial holderSubstantial Holders02003
21 Apr 2026, 03:30Notice of Annual General MeetingMeetings & Governance08001, 08004
16 Apr 2026, 23:51Change in substantial holdingSubstantial Holders02002
15 Apr 2026, 03:28Change in substantial holdingSubstantial Holders02002
9 Apr 2026, 04:26Cleansing StatementSecurities Administration06018
9 Apr 2026, 04:22Application for quotation of securities - OSXOther06020
3 Apr 2026, 05:19Change in substantial holdingSubstantial Holders02002
1 Apr 2026, 07:29Appendix 4G and Corporate Governance StatementCompany Administration03024, 03025
1 Apr 2026, 07:28Annual Report to ShareholdersFinancial Results03001, 03002, 03011, 03012, 03013, 03020
27 Mar 2026, 05:50Cleansing NoticeSecurities Administration06018
27 Mar 2026, 05:40Notification regarding unquoted securities - OSXOther06021
27 Mar 2026, 05:35Further Drawdown of T2 of the Redeemable Convertible NotesSecurities AdministrationMS06009
26 Mar 2026, 20:28OSX receives AUD 520,000 from MajetonCompany Update11001
20 Mar 2026, 04:11Expiry of Listed OptionsSecurities Administration06009
18 Mar 2026, 05:51Change in substantial holdingSubstantial Holders02002
13 Mar 2026, 05:34Clarification - agreement for injectable regen bone fillerCompany UpdateMS11001
12 Mar 2026, 20:27OSX signs agreement for injectable regenerative bone fillerCompany UpdateMS11001
11 Mar 2026, 06:43Change in substantial holdingSubstantial Holders02002
10 Mar 2026, 20:27OSX and NUH to co-develop surgical guide in neurosurgeryCompany Update11001
1–50 of 118
1 / 3